{"count": 2, "results": [{"_id": "32761160", "pmid": 32761160, "pmcid": "PMC7411539", "title": "Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment", "journal": "JAMA Netw Open", "authors": ["Hajjar I", "Okafor M", "McDaniel D", "Obideen M", "Dee E", "Shokouhi M", "Quyyumi AA", "Levey A", "Goldstein F"], "date": "2020-08-03T00:00:00Z", "doi": "10.1001/jamanetworkopen.2020.12252", "meta_date_publication": "2020 Aug 3", "meta_volume": "3", "meta_issue": "8", "meta_pages": "e2012252", "score": 50290.973, "text_hl": "These findings suggest that in older adults with @<m>DISEASE_Cognitive_Dysfunction</m> @DISEASE_MESH:D060825 @@@MCI@@@, 1-year treatment with @CHEMICAL_candesartan @CHEMICAL_MESH:C081643 @@@candesartan@@@ had superior neurocognitive outcomes compared with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@. ", "citations": {"NLM": "Hajjar I, Okafor M, McDaniel D, Obideen M, Dee E, Shokouhi M, Quyyumi AA, Levey A, Goldstein F. Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment JAMA Netw Open. 2020 Aug 3;3(8):e2012252. PMID: 32761160", "BibTeX": "@article{32761160, title={Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment}, author={Hajjar I and Okafor M and McDaniel D and Obideen M and Dee E and Shokouhi M and Quyyumi AA and Levey A and Goldstein F}, journal={JAMA Netw Open}, volume={3}, number={8}, pages={e2012252}}"}}, {"_id": "22203459", "pmid": 22203459, "title": "Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging.", "journal": "Age (Dordr)", "authors": ["Solfrizzi V", "Scafato E", "Frisardi V", "Seripa D", "Logroscino G", "Kehoe PG", "Imbimbo BP", "Baldereschi M", "Crepaldi G", "Di Carlo A", "Galluzzo L", "Gandin C", "Inzitari D", "Maggi S", "Pilotto A", "Panza F", "Italian Longitudinal Study on Aging Working Group"], "date": "2013-04-01T00:00:00Z", "doi": "10.1007/s11357-011-9360-z", "meta_date_publication": "2013 Apr", "meta_volume": "35", "meta_issue": "2", "meta_pages": "441-53", "score": 50054.08, "text_hl": "However, within-class differences linked to different chemical structures and/or drug potencies may exist, with a possible effect of the @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ sub-groups in reducing the risk of incident @<m>DISEASE_Cognitive_Dysfunction</m> @DISEASE_MESH:D060825 @@@MCI@@@.", "citations": {"NLM": "Solfrizzi V, Scafato E, Frisardi V, Seripa D, Logroscino G, Kehoe PG, Imbimbo BP, Baldereschi M, Crepaldi G, Di Carlo A, Galluzzo L, Gandin C, Inzitari D, Maggi S, Pilotto A, Panza F, Italian Longitudinal Study on Aging Working Group. Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging. Age (Dordr). 2013 Apr;35(2):441-53. PMID: 22203459", "BibTeX": "@article{22203459, title={Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging.}, author={Solfrizzi V and Scafato E and Frisardi V and Seripa D and Logroscino G and Kehoe PG and Imbimbo BP and Baldereschi M and Crepaldi G and Di Carlo A and Galluzzo L and Gandin C and Inzitari D and Maggi S and Pilotto A and Panza F and Italian Longitudinal Study on Aging Working Group}, journal={Age (Dordr)}, volume={35}, number={2}, pages={441-53}}"}}]}